Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV. - Wikidata - awgldk - TriplyDB

Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV.

Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV.

http://www.wikidata.org/entity/Q48284053

about

Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Novel poly(ethylene oxide)-b-poly(propylene oxide) copolymer-glucose conjugate by the microwave-assisted ring opening of a sugar lactone.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV/AIDS.Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system Small RNA drugs for prion disease: a new frontier.Nanotechnology: a magic bullet for HIV AIDS treatment.Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting.Nano-ART and NeuroAIDS.In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy.Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections.Rifampicin-loaded 'flower-like' polymeric micelles for enhanced oral bioavailability in an extemporaneous liquid fixed-dose combination with isoniazid.Development of plumbagin-loaded phospholipid-Tween® 80 mixed micelles: formulation, optimization, effect on breast cancer cells and human blood/serum compatibility testing.Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying method.Novel poly(vinyl alcohol)-based amphiphilic nanogels by non-covalent boric acid crosslinking of polymeric micelles.Tetronic® 904-containing polymeric micelles overcome the overexpression of ABCG2 in the blood-brain barrier of rats and boost the penetration of the antiretroviral efavirenz into the CNS.Protoporphyrin IX-modified chitosan-g-oligo(NiPAAm) polymeric micelles: from physical stabilization to permeability characterization in vitro.Harnessing nanostructured systems for improved treatment and prevention of HIV disease

P2860

Q30387307-AA4C399F-7C21-4F69-BFC3-4ECCFAAAAACC Q30845058-7DE764E0-C9D0-4D23-89C2-68996C6B5D2C Q34797004-2520E598-7A76-4DAA-9663-416954986A99 Q36338109-5EFEC265-63F0-4F8E-AC00-AD434FC69771 Q37013364-9ECEC1EB-7C4C-4C4F-9EBA-71184FB2BA48 Q37698620-42DFCFE5-EE75-4A79-80FF-8A7699D0E47F Q38121120-DF155066-36A6-4C22-BEBA-541F959F2424 Q38190581-E3FD1F76-6D8E-4EF7-A851-824FF5705D3B Q38495022-111DE03B-8A05-4823-9EAF-B99E7B1476C6 Q38706868-FF733526-F44C-4490-9B35-E5DD8185F43F Q38823456-B2F789A5-C619-44BE-806B-35FA197F6B2B Q39243464-43B5B372-9768-4D3B-9F5C-4A3C87EB51BF Q40105941-B5FB7559-57E3-4F55-92FF-84F01A87DF7B Q43882895-839757D7-1C9A-43CC-AFA2-22404030B1DE Q44794686-D84E197F-0185-448E-9FB6-9765B912FB43 Q46907206-EF1F0600-3323-4040-8B84-F8227FBC7295 Q47580663-5D150CD8-F6D4-4A22-AB4E-33C0F5A8B825 Q50948205-4DBDA911-5FF4-4D56-AD14-F4EDCA950A17 Q51090226-6C049394-833A-4CBF-A90C-42F34E8E90F8 Q56992437-7E603AEA-D333-4DBF-9F8C-7B396599FD85

P2860

Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV.

http://www.wikidata.org/entity/Q48284053

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Intranasal administration of a ...... targeting to the brain in HIV.

@en

Intranasal administration of a ...... targeting to the brain in HIV.

@nl

type

label

Intranasal administration of a ...... targeting to the brain in HIV.

@en

Intranasal administration of a ...... targeting to the brain in HIV.

@nl

prefLabel

Intranasal administration of a ...... targeting to the brain in HIV.

@en

Intranasal administration of a ...... targeting to the brain in HIV.

@nl

P1433

Q48284053-72DD4866-F141-4E9C-9552-3592D23B4FA1

P1476

Q48284053-8F3F5BFB-1CE0-4C96-8DCA-8688A13C48DE

P2093

Q48284053-72173DE3-2F4F-4F5E-91F9-BD7DD029C9C4

Q48284053-72B14198-F23B-4A51-9815-6CE4101CC6AD

Q48284053-F9EC102B-471A-4FBD-A87E-1415EC40464F

Q48284053-F9EE69DB-81C2-4114-815A-A2C8F853716F

P2860

Q48284053-00F79B9F-37FA-466D-B677-2F4356521364

Q48284053-03F4656B-94EC-4D31-A19E-27F14F314A60

Q48284053-0C245FA7-BA76-42DF-AE7B-3D36FB7BEA0D

Q48284053-0DEC8A34-9941-4842-A749-315F6832415A

Q48284053-13EA878B-05FD-4BDA-B2C0-CC4482066C12

Q48284053-14D12FF1-3D1C-4D7C-97F4-45248125898D

Q48284053-17694309-ADE5-4D27-A09A-82232107CB3C

Q48284053-17F44527-26F0-4F75-91BA-DADDFF34948C

Q48284053-1B18F2B5-5CD0-46EA-B4ED-C5A67DA758AD

Q48284053-1CDD840E-07BE-4EA7-A85B-1F6BF71A9E0E

P304

Q48284053-66D02F50-FDAF-4594-9988-AB5F6D95A6A5

P31

Q48284053-A129D7A7-BA47-4344-ADB0-9D3E418955D8

P356

Q48284053-05626B49-1962-447A-B100-E0C63082918D

P433

Q48284053-19A3D999-AF55-4DEE-A203-23DE95FEBB33

P478

Q48284053-0C89CEE2-8845-46A0-8561-AB76D125EF3B

P577

Q48284053-C1956DCD-DE2D-442F-8E85-4C54AE3AD601

P5875

Q48284053-F5432933-ADCB-422B-8ED5-A0D068B62959

P698

Q48284053-AF32A1A3-2FE3-4C53-8DA9-D025759B3954

P921

Q48284053-FB2317C7-9D2C-4D26-AEA1-085D35425ED2

P356

P1433

P1476

Intranasal administration of a ...... targeting to the brain in HIV.

@en

P2093

Alejandro Sosnik

http://www.w3.org/2001/XMLSchema#string

Christian Hocht

http://www.w3.org/2001/XMLSchema#string

Diego A Chiappetta

http://www.w3.org/2001/XMLSchema#string

Javier A W Opezzo

http://www.w3.org/2001/XMLSchema#string

P2860

P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution

Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo.

Mixed micelles formed from graft and diblock copolymers for application in intracellular drug delivery.

Repair of bone defect using bone marrow cells and demineralized bone matrix supplemented with polymeric materials.

P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs.

Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse transcriptase inhibitors.

Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice

Loss of neuronal integrity during progressive HIV-1 infection of humanized mice.

Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages.

TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs

P304

223-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.12.104

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233749209

http://www.w3.org/2001/XMLSchema#string

P698

23173734

http://www.w3.org/2001/XMLSchema#string

P921